Search
for
Sort by
Research 30 of 44
- Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor
- Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth Factor
- A Case of Hair Change and Acneiform Eruption Induced by ZD1839 (Iressa$^{(R)}$)
- Oral Combination Treatment of Gefitinib (IressaTM) and Sasam-Kyeongokgo: Synergistic Effects on the NCI-H520 Tumor Cell Line
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
- Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib
- Acneiform eruptions caused by an epidermal growth factor receptor-tyrosine kinase inhibitor ZD 1839
- [ADAPTIVE REGULATORY MECHANISMS OF ALOPECIA AREATA].
- Alopecia Areata
- 5-Alpha-Reductase Inhibitors in the Treatment of Male Androgenetic Alopecia: Clinical Experience
- Clinical guidelines of ukrainian hair research society. diagnosis and treatment of alopecia areata
- RELAÇÃO ENTRE A COVID-19 E A DOENÇA DE KAWASAKI EM INFANTES
- Cosmeceutical Applications of Phlorotannins from Brown Seaweeds
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Cetuximab-Associated Elongation of the Eyelashes
- Green tea in dermatology - myths and facts
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Management of Toxicities of Targeted Therapies
- Hair Growth After Gefitinib Treatment
- Cutaneous drug reactions
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Convergent Evolution of Cysteine-Rich Keratins in Hard Skin Appendages of Terrestrial Vertebrates
- α-Mangostin, a safe and natural product as a candidate skin-whitening agent
- Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- Epidermal growth factor receptor inhibitors and hair
- Poly(rC) binding protein 2 acts as a negative regulator of IRES-mediated translation of Hr mRNA
- Activation of Nrf2 in keratinocytes causes chloracne (MADISH)‐like skin disease in mice